Adaptation of an in vitro phospholipidosis assay to an automated image analysis system

Toxicology Mechanisms and Methods

Volumn 17, Issue 2, 2007, Pages 77-86

  Schurdak, Mark E ^a   Vernetti, Lawrence A ^a   Abel, Stephen J ^a   Thiffault, Christine ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Cationic Amphiphilic Drugs; Cell Based Assay; Fluorescence Microscopy; High Content Screening; Phospholipidosis; Rat Hepatocytes

Indexed keywords

AMANTADINE; CARBON; CHLOROQUINE; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; FLUOXETINE; GENTAMICIN; IMIPRAMINE; PERHEXILINE; PHOSPHORYLCHOLINE; PROPRANOLOL; TAMOXIFEN;

ANIMAL CELL; ARTICLE; AUTOMATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; LIPIDOSIS; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALIA; RATTUS;

EID: 33846959513     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510600860185     Document Type: Article

References (33)

1. Casartelli, A., Bonato, M., Cristofori, P., Crivellente, F., Dal Negro, G., Masotto, I., Mutinelli, C., Valko, K., and Bonfante, V. 2003. A cell-based approach for the early assessment of phospholipidogenic potential in pharmaceutical research and drug development. Cell Biol. Toxicol. 19:161-176.
2. De Broe, M. E., Paulus, G. J., Verpooten, G. A., Roels, F., Buyssens, N., Wedeen, R., and Tulkens, P. 1984. Early effects of gentamicin, tobramycin and amikacin on the human kidney. Kidney Int. 25:643-652.
3. Dokko, R. C., Cho, B. H., and Chung, B. H. 1998. Cellular uptake of stearic, oleic, linoleic, and linolenic acids and their effects on synthesis and secretion of lipids in Hep-G2 cells. Int. J. Biochem. Cell. Biol. 30:65-76.
4. Drenckhahn, D., Jacobi, B., and Lullmann-Rauch, R. 1983. Corneal lipidosis in rats treated with amphiphilic cationic drugs. Arzneimittelforschung 33:827-831.
5. Elliget, K. A., and Kolaja, G. J. 1983. Preparation of primary cultures of rat hepatocytes suitable for in vitro toxicity testing. J. Tissue Culture Methods 8:1-6.
6. Feldman, S., Wang, M.-Y., and Kaloyanides, G. J. 1982. Aminoglycosides induce a phospholipidosis in renal cortex of the rat: an early manifestation of nephrotoxicity. J. Pharmacol. Exp. Ther. 220:514-520.
7. Finbloom, D. S., Silver, K., Newsome, D. A., and Gunkel, R. 1985. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J. Rheumatol. 12:692-694.
8. Gonzalez-Rothi, R. J., Zander, D. S., and Ros, P. R. 1995. Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 107:1763-1765.
9. Gum, R. J., Hickman, D., Fagerland, J. A., Heindel, M. A., Gagne, G. D., Schmidt, J. M., Michaelides, M. R., Davidsen, S. K., and Ulrich, R. G. 2001. Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes. Biochem. Pharmacol. 62:1661-1673.
10. Hallberg, A., Naeser, P., and Andersson, A. 1990. Effects of long-term chloroquine exposure on the phospholipids metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol 68:125-130.
11. Horn, J. W., Jensen, C. B., White, S. L., Laska, D. A., Novilla, M. N., Giera, D. D., and Hoover, D. M. 1996. In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389. Fundam. Appl. Toxicol. 32:205-216.
12. Hostetler, K. Y., and Matsuzawa, Y. 1981. Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C. Biochem. Pharmacol. 30:1121-1126.
13. Hruban, Z. 1984. Pulmonary and generalized lysosomal storage induced by amphiphilic drugs. Environ. Health Perspect. 55:53-76.
14. Joshi, U. M., Rao, P., Kodavanti, S., Coudert, B., Dwyer, T. M., and Mehendale, H. M. 1988. Types of interaction of amphiphilic drugs with phospholipid vesicles. J. Pharmacol. Exp. Ther. 246:150-157.
15. Kacew, S. 1985. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity. J. Pharmacol. Exp. Ther. 232:239-243.
16. Kaloyanides, G. J., and Pastoriza-Munoz, E. 1980. Aminoglycoside nephrotoxicity. Kidney Int. 18:571-582.
17. Kodavanti, U. P., Lockard, V. G., and Mehendale, H. M. 1990. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats. J. Biochem. Toxicol. 5:245-251.
18. Kubo, M., Gardner, M. F., and Hostetler, K. Y. 1986. Binding of propranolol and gentamicin to small unilamellar phospholipids vesicles. Contribution of ionic and hydrophobic forces. Biochem. Pharmacol. 35:3761-3765.
19. Kubo, M., and Hostetler, K. Y. 1987. Metabolic basis of diethylaminoethoxyhexestrol-induced phospholipid fatty liver. Am. J. Physiol. 252:E375-E379.
20. Lullmann, H., Lullmann-Rauch, R., and Wassermann, O. 1978. Lipidosis induced by amphiphilic cationic drugs. Biochem. Pharmacol. 27:1103-1108.
21. Matsuzawa, Y., and Hostetler, K. Y. 1980. Studies on drug-induced lipidosis: subcellular locatlization of phospholipids and cholesterol in the liver of rat treated with chloroquine or 4′,4′-bis (diethylaminoethoxy)-α, β-diethyldiphenylethane. J. Lipid Res. 21:202-214.
22. Montenez, J.-P., Van Bambeke, F., Piret, J., Brasseur, R., Tulkens, P. M., and Mingeot-Leclercq, M.-P. 1999. Interactions of macrolide antibiotics (erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. Toxicol. Appl. Pharmacol. 156:129-140.
23. Oikawa, H., Maesawa, C., Sato, R., Oikawa, K., Yamada, H., Oriso, S., Ono, S., Yashima-Abo, A., Kotani, K., Suzuki, K., and Masuda, T. 2005. Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report. World J. Gastroenterol. 11:5394-5397.
24. Pessayre, D., Bichara, M., Degott, C., Potet, F., Benhamou, J. P., and Feldmann, G. 1979. Perhexiline maleate-induced cirrhosis. Gastroenterology 76:170-177.
25. Reasor, M. J., and Kacew, S. 1996. An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity. Proc. Soc. Exp. Biol. Med. 212:297-304.
26. Ruben, Z., Anderson, S. N., Rorig, K. J., Hribar, J. D., and Bible, R. H. Jr. 1985. The pH dependence of disobutamide-induced clear cytoplasmic vacuoles in cultured cells. Proc. Soc. Exp. Biol. Med. 180:84-91.
27. Ruben, Z., Doss, D. C., Rorig, K. J., and Anderson, S. N. 1989. Disobutamide: a model agent for investigating intracellular drug storage. Toxicol. Appl. Pharmacol. 97:57-71.
28. Sawada, H., Takami, K., and Asahi, S. 2005. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.. Tox. Sci. 83:282-292.
29. Seglen, P. O. 1976. Preparation of isolated rat liver cells. Meth. Cell Biol. 13:29-83.
30. Tashiro, Y., Watanabe, Y., and Enomoto, Y. 1983. Experimental phospholipidosis induced by 4′,4′-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations. Acta Pathol. Jpn. 33:929-942.
31. Ulrich, R. G., Kilgore, K. S., Sun, E. L., Cramer, C. T., and Ginsburg, L. C. 1991. An in vitro fluorescence assay for the detection of drug-induced cytoplasmic lamellar bodies. Tox. Methods. 1:89-105.
32. Vonderfecht, S. L., Stone, M. L., Eversole, R. R., Yancey, M. F., Schuette, M. R., Duncan, B. A., and Ware, J. A. 2004. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Tox. Pathol. 32:318-325.
33. Xia, A., Ying, F., Hansson, A. L., Karlsson, H., Xie, Y., Bergstrand, A., DePierre, J. W., and Nässberger, L. 2000. Antidepressant-induced lipidosis with special reference to tricyclic compounds. Prog. Neurobiol. 60:501-512.